These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19439247)

  • 1. Association analysis between the C-1291G polymorphism in the promoter region of the adrenergic alpha2A receptor gene and polydipsia in schizophrenia.
    Yamaguchi W; Shinkai T; Inoue Y; Utsunomiya K; Sakata S; Fukunaka Y; Yamada K; Chen HI; Hwang R; Ohmori O; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):499-502. PubMed ID: 19439247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females.
    Fukutake M; Hishimoto A; Nishiguchi N; Nushida H; Ueno Y; Shirakawa O; Maeda K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1428-33. PubMed ID: 18547701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (-485C>T) and schizophrenia.
    Inoue Y; Shinkai T; Utsunomiya K; Sakata S; Fukunaka Y; Yamaguchi W; Yamada K; Chen HI; Hwang R; Ohmori O; Nakamura J
    Neurosci Lett; 2009 Mar; 452(1):72-4. PubMed ID: 19150389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
    Clark DA; Arranz MJ; Mata I; Lopéz-Ilundain J; Pérez-Nievas F; Kerwin RW
    Biol Psychiatry; 2005 Sep; 58(6):435-9. PubMed ID: 16043131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder.
    Lee HY; Kang RH; Paik JW; Jeong YJ; Chang HS; Han SW; Lee MS
    Brain Res; 2009 Mar; 1262():1-6. PubMed ID: 19401164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alpha2A-adrenoceptor C-1291G genotype and maltreatment on hyperactivity and inattention in adolescents.
    Kiive E; Kurrikoff T; Mäestu J; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):219-24. PubMed ID: 19922756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADRA2A polymorphism and smoking in a Turkish population.
    Karahalil B; Coskun E; Emerce E
    Toxicol Ind Health; 2008 Apr; 24(3):171-6. PubMed ID: 18842695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families.
    Xu C; Schachar R; Tannock R; Roberts W; Malone M; Kennedy JL; Barr CL
    Am J Med Genet; 2001 Mar; 105(2):159-62. PubMed ID: 11304829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of schizophrenia with a promoter polymorphism in the dopamine D2 receptor gene].
    Peng DH; Wang GH; Cheng ZL; Zhang DX; Jiang KD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):94-5. PubMed ID: 15696493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive effect of MTHFR and ADRA2A gene polymorphisms on pathogenesis of schizophrenia.
    Lochman J; Plesník J; Janout V; Povová J; Míšek I; Dvořáková D; Šerý O
    Neuro Endocrinol Lett; 2013; 34(8):792-7. PubMed ID: 24522021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the alpha2-adrenergic system in polydipsia in schizophrenic patients: a pilot study.
    Hayashi T; Nishikawa T; Koga I; Uchida Y; Horiguchi J; Yamawaki S
    Psychopharmacology (Berl); 1997 Apr; 130(4):382-6. PubMed ID: 9160855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects.
    Meerabux J; Iwayama Y; Sakurai T; Ohba H; Toyota T; Yamada K; Nagata R; Irukayama-Tomobe Y; Shimizu H; Yoshitsugu K; Ohta K; Yoshikawa T
    Biol Psychiatry; 2005 Sep; 58(5):401-7. PubMed ID: 15978554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.
    Lochman J; Balcar VJ; Sťastný F; Serý O
    Psychiatry Res; 2013 Jan; 205(1-2):7-12. PubMed ID: 22940547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco smoking and the ADRA2A C-1291G polymorphism.
    Prestes AP; Marques FZ; Hutz MH; Roman T; Bau CH
    J Neural Transm (Vienna); 2007; 114(11):1503-6. PubMed ID: 17612790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of alpha 2A adrenergic receptor gene (ADRAlpha2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis.
    Sikander A; Rana SV; Sharma SK; Sinha SK; Arora SK; Prasad KK; Singh K
    Clin Chim Acta; 2010 Jan; 411(1-2):59-63. PubMed ID: 19833115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U; Tug E; Kara M; Namli M
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):307-12. PubMed ID: 18588591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lack of association between the insertion/deletion polymorphism in the serotonin transporter gene and schizophrenia].
    Kapelski P; Hauser J; Dmitrzak-Weglarz M; Skibińska M; Słopień A; Kaczmarkiewicz-Fass M; Rajewska A; Gattner K; Czerski PM
    Psychiatr Pol; 2006; 40(5):925-35. PubMed ID: 17217236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perception of emotion in facial stimuli: The interaction of ADRA2A and COMT genotypes, and sex.
    Tamm G; Kreegipuu K; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():87-95. PubMed ID: 26234518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia.
    Matsumoto C; Shinkai T; De Luca V; Hwang R; Hori H; Lanktree M; Ohmori O; Kennedy JL; Nakamura J
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):245-53. PubMed ID: 15850500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association of a cholecystokinin promoter variant to schizophrenia.
    Wang Z; Wassink T; Andreasen NC; Crowe RR
    Am J Med Genet; 2002 Jul; 114(5):479-82. PubMed ID: 12116180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.